Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
about
Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature.Update on ranolazine in the management of angina.Extended-release ranolazine: critical evaluation of its use in stable angina.Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.Evaluating symptoms to improve quality of life in patients with chronic stable angina.Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.A systematic literature review of cardiovascular event utilities.Assessing quality-of-life outcomes in cardiovascular clinical research.Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery.Dyspnea Among Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Intervention: Prevalence and Predictors of Improvement.Cardiac Arrhythmias Related to Sodium Channel Dysfunction.Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?
P2860
Q33669496-C30FF048-D67F-4306-A208-E9EBCE898A2BQ33831222-BB8EACAC-1F25-41A1-A929-17CFD8EE5A59Q35193935-A31754B1-3C6F-4480-A673-14E5671766E4Q35873307-E20443F9-C863-408C-9866-970F6FF77493Q36258672-963947E8-0C71-4B59-ADAE-31FE12DC03D4Q37140881-5A134770-F16D-4481-83B6-D6B43C6C1DA3Q37199774-AD7D0ECE-65C3-4250-82A4-85060EC3F67CQ37449790-28239FBE-7A20-49EA-B23E-FEF5B8844AB2Q38074900-6110BDE5-1024-4A82-9527-8CDB5478417CQ38157041-05ED3333-1BF7-4D75-8D18-D41076328F10Q38737960-34A62A18-4CBB-4C6F-839C-BB7EB52E3CAFQ39397055-7F8A9143-2BEE-41AD-867C-34024EB4CE53Q44627954-AD0A684D-C9FA-48EB-AE8D-C98CE632D941Q47565458-5B3EB780-14C0-4F0F-AC8F-74F080A3BDBEQ47720327-711545B5-30EE-4742-8CD8-E95C0CB41B83Q55080711-8886ABF7-BB01-4504-8C66-3A0DE16FA203
P2860
Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@ast
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@en
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@nl
type
label
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@ast
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@en
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@nl
prefLabel
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@ast
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@en
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@nl
P2093
P1476
Effects of ranolazine on disea ...... RLIN-TIMI 36 randomized trial.
@en
P2093
Benjamin M Scirica
David A Morrow
David J Cohen
Elizabeth M Mahoney
Kaijun Wang
MERLIN-TIMI 36 Investigators
Suzanne V Arnold
P304
P356
10.1161/CIRCOUTCOMES.108.798009
P577
2008-11-05T00:00:00Z